AstraZeneca PLC (AZN) And Bristol-Myers Squibb Company (BMY) Release: Xigduo™ (Dapagliflozin And Metformin Hydrochloride) Receives Positive CHMP Opinion In The European Union For The Treatment Of Type 2 Diabetes
11/22/2013 10:13:56 AM
More...
|
Bristol-Myers Squibb Company (BMY) Marks World Diabetes Day With Four Grants Addressing Link Between Diabetes, Depression And Distress
11/14/2013 9:36:10 AM
More...
|
Bristol-Myers Squibb Company (BMY) Shakes Up Senior Management Team
11/14/2013 9:04:15 AM
More...
|
Bristol-Myers Squibb Company (BMY) Shakes Up Senior Management Team
11/14/2013 9:04:15 AM
More...
|
AstraZeneca PLC (AZN) Could Up Stake in Bristol-Myers Squibb Company (BMY) Diabetes JV
11/8/2013 7:57:57 AM
More...
|
Bristol-Myers Squibb Company (BMY) Submits First All-Oral, Interferon-Free and Ribavirin-Free Treatment Regimen for Regulatory Review in Japan for Patients With Chronic Hepatitis C Infection
11/4/2013 7:11:00 AM
More...
|
IncellDx, Inc. Signs Agreement With Bristol-Myers Squibb Company (BMY) Related to the Development of an Assay for a Companion Diagnostic Test
10/29/2013 7:06:37 AM
More...
|
Bristol-Myers Squibb Company (BMY) Touts Promising Phase 2b Data on Rheumatoid Arthritis Clazakizumab
10/28/2013 6:31:05 AM
More...
|
Bristol-Myers Squibb Company (BMY) Prices $1.5 Billion of Senior Notes
10/25/2013 9:55:21 AM
More...
|
Ex-Bristol-Myers Squibb Company (BMY) Executive Gets One Year in Prison for Insider Trading
10/24/2013 6:41:15 AM
More...
|
|